Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2022 | Should all adverse effects of a medication be discussed to a patient?

Morris Levin, MD, University of California, San Francisco, CA, comments on whether a patient should be informed of every side effect upon prescription of a certain medication. Despite the perceived moral obligation to discuss all potential adverse event, studies suggest that this may lead to increased incidences of side effects occurring as well as lower patient medication adherence. Whilst common and expected side effects should be mentioned, certain adverse events may best be mentioned only when necessary. This interview was conducted during the 2022 World Congress on Controversies in Neurology (CONy) meeting.

Disclosures

Dr Levin was a one-time advisory board to: Biohaven, BDSI, Upsher Smith, AbbVie; Consults on hourly fee for Mable/Neurolytic healthcare; Consults for stock holdings for Percept; Has royalties in Oxford University Press and Anadem Publishing.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.